Stock price when the opinion was issued
It is one he quite likes in his Cannabis portfolio. They are the number one selling chocolate infused with THC. They can also infuse it into sugar for baking. The company has been ramping up as of late. Later this year we should see cash flow positive from this company and then it will hit the radar screen of many investors.
Medical cannabis. The stock hasn't performed well lately, nor has the sector. The small- and medium-sized cannabis companies have underperformed compared to the big ones. There are worries about too much supply in the market. He likes NDVA and was a past pick. Management has executed as planned by growing their facility. The market isn't rewarding them. Overall, there's a finite number of dollars to invest in cannabis, so money has left the smaller guys over supply fears to invest in the big guys.